B-cell chronic lymphocytic leukemiaNews & Research
5 curated articles for B-cell chronic lymphocytic leukemia — FDA updates, peer-reviewed research, clinical-trial milestones, and sponsor press releases. Sorted newest-first.
- Redox biology Apr 21, 2026
Cell surface thiol-disulfide regulation in cancer: Mechanisms, implications, and theranostic strategies.
Redox homeostasis is frequently disrupted in cancer and contributes to tumor progression, metastasis, and therapy resistance. This review focuses on how thioredoxin-1 (TXN1), thioredoxin reductase-1 (TXNRD1), and members of the protein disulfide isomerase (PDI) family regulate thiol-disulfide balanc...
Why it matters: Recent peer-reviewed research on B-cell chronic lymphocytic leukemia that may be relevant for patients and caregivers.
- bioRxiv : the preprint server for biology Apr 10, 2026
Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eμ-TCL1 mice.
The composition and function of the gut microbiome have been shown to contribute to both health and disease. One of the most powerful modulators of microbial composition and function is diet. Using the Eμ-TCL1 murine model of B-cell chronic lymphocytic leukemia (CLL), we assigned male and fema...
Why it matters: Recent peer-reviewed research on B-cell chronic lymphocytic leukemia that may be relevant for patients and caregivers.
- Cell reports Mar 27, 2026
Early-life B cell memory is archived in the mouse B-1 cell compartment and drives chronic lymphocytic leukemia-like disease.
The adult B cell pool is a mosaic comprising short-lived naive B cells and long-lived memory. Using genetic time stamping, we have previously shown that early-life-origin (ELO) B cells contribute substantially to the adult mouse immune system. Here, we show that they share a memory-like signature, w...
Why it matters: Recent peer-reviewed research on B-cell chronic lymphocytic leukemia that may be relevant for patients and caregivers.
- International journal of genomics Feb 20, 2026
Epigenetics in B-CLL.
B-cell chronic lymphocytic leukemia (B-CLL) is the most common hematological malignancy in adults. Its clinical course is heterogeneous, ranging from indolent forms with slow progression to aggressive variants refractory to conventional treatment. In recent years, it has been shown that epigenetic a...
Why it matters: Recent peer-reviewed research on B-cell chronic lymphocytic leukemia that may be relevant for patients and caregivers.
- Bioorganic & medicinal chemistry letters Dec 31, 2025
Discovery of novel imidazo[4,5-b]pyridine derivatives as noncovalent reversible Bruton's tyrosine kinase inhibitors.
Bruton's tyrosine kinase (BTK) has emerged as a validated therapeutic target for B-cell malignancies and autoimmune disorders, and covalent BTK inhibitors have demonstrated remarkable clinical efficacy. However, because of concerns regarding their off-target effects and safety profiles, there is res...
Why it matters: Recent peer-reviewed research on B-cell chronic lymphocytic leukemia that may be relevant for patients and caregivers.
More on B-cell chronic lymphocytic leukemia
Articles aggregated from peer-reviewed journals (PubMed), sponsor press releases, SEC 8-K filings, and FDA announcements. Original-source links are preserved on each article page. Editorial tags (Breaking / Notable / Update) reflect UniteRare's curation-time priority assessment.